Replies to post #15027 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

[Semi-OT]—CHRS has run into some trouble showing bioequivalence to Neulasta:

#msg-119019743

CHRS management also has some credibility issues, IMO.